ARTICLE
26 December 2019

Update: What Is The Status Of Caster Semenya's Case?

Sa
Shepherd and Wedderburn LLP

Contributor

Shepherd and Wedderburn is a leading, independent Scottish-headquartered UK law firm, with offices in Edinburgh, Glasgow, Aberdeen, London and Dublin. With a history stretching back to 1768, establishing long-standing relationships of trust, rooted in legal advice and client service of the highest quality, is our hallmark.
Semenya did not take part in the World Athletics Championships in autumn 2019.
UK Media, Telecoms, IT, Entertainment
To print this article, all you need is to be registered or login on Mondaq.com.

Caster Semenya, the 28-year-old South African middle-distance runner and 800 metres Olympic champion, has been competing on the world stage for almost a decade.

Recently, however, she been embroiled in a legal dispute with the International Association of Athletics Federation (IAAF) regarding controversial regulations targeting women with 'Difference of Sexual Development' (DSD). The intention of the regulations is to prevent women with high levels of testosterone from participating in certain gender-affected sports unless they consent to taking hormone-suppressing medication.

Semenya did not take part in the World Athletics Championships in autumn 2019. However, she has been vocal in the past about her refusal to comply with the regulations, stating: "No woman should be subjected to these rules. I thought hard about not running the 800 metres in solidarity unless all women can run free. But I will run now to show the IAAF that they cannot drug us."

Women with hyperandrogenism in sports has been a matter of contention for many years. Semenya is not the first athlete to fight for her right to compete, nor is she the first to face harsh scrutiny and disparaging comments as a result of her failure to conform.

In an attempt to defend the regulations in a recent interview with Sports Magazine, IAAF treasurer José Maria Odriozola went as far as to describe Semenya as "biologically a man". Semenya is a cisgender woman – identifying with her gender assigned at birth – and she identifies as such.

The IAAF maintains that it does not wish to discriminate against women with DSD. It claims the regulations are necessary in order to level the playing field and ensure that women with lower testosterone levels are not pushed out of the top rankings in their chosen sports.

The Court of Arbitration for Sports (CAS), based in Switzerland, heard Semenya's case in March 2019. The CAS sided with the IAAF, acknowledging that the regulations were discriminatory but finding them "reasonable and necessary" to "preserve the integrity of women's sports".

The trajectory of the case going forward is uncertain. Semenya is set to appeal the decision, and since the CAS sits in Lausanne and is governed by Swiss Law, it will be the Federal Supreme Court of Switzerland that will hear her appeal.

Initially, the Supreme Court granted Semenya temporary suspension of the IAAF's regulations to allow her to carry on competing. However, this suspension was later revoked. As such, it is impossible to predict what the outcome of the appeal will be and what will come thereafter.

Should her appeal before the Supreme Court in Switzerland fail, Semenya could take her case all the way to the European Court of Human Rights in Strasbourg.

Semenya has announced plans to make her football debut in 2020 after joining JVW FC, a women's team in South Africa. She has stated no human being will ever stop her from running – it remains to be seen if this statement will hold true.

Due to the high volume of enquiries we receive, we only provide advice to those who arrange a consultation with our immigration team. To do so, please get in touch about your situation and availability.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More